CryoLife, Inc. (NYSE:CRY)

CAPS Rating: 5 out of 5

The Company develops and commercializes biomaterials, implantable medical devices, and preserves and distributes human tissues for cardiovascular and vascular transplant applications.

Recs

0
Player Avatar drinkmorebeer96 (66.38) Submitted: 11/24/2010 11:54:40 AM : Outperform Start Price: $5.50 CRY Score: -26.28

This pick is pure speculation.

Featured Broker Partners


Advertisement